Ayaka Morimoto

Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies

Toshiki Tezuka, Keisuke Takahata, Morinobu Seki et al. · Brain Communications · 2021 · 80 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management

Sho Shimohama, Toshiki Tezuka, Keisuke Takahata et al. · Neurology · 2022 · 44 citations

Medicine, Neurology, Neuroscience +17

Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status

Shogyoku Bun, Daisuke Ito, Toshiki Tezuka et al. · Alzheimer s Research & Therapy · 2023 · 35 citations · Full text

Medicine, Neurology, Neuroscience +17

Plasma biomarkers for early detection of alzheimer’s disease: a cross-sectional study in a Japanese cohort

Masahito Kubota, Shogyoku Bun, Keisuke Takahata et al. · Alzheimer s Research & Therapy · 2025 · 17 citations · Full text

Medicine, Neurology, Neuroscience +17

Findings of <scp>¹⁸F‐PI</scp>‐2620 tau <scp>PET</scp> imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample

Shogyoku Bun, Sho Moriguchi, Toshiki Tezuka et al. · Neuropsychopharmacology Reports · 2022 · 10 citations · Full text

Medicine, Neurology, Nuclear Medicine +17